|
|
|
|
LEADER |
04009nam a2200769Ia 4500 |
001 |
10.1002-jcla.23988 |
008 |
220427s2021 CNT 000 0 und d |
020 |
|
|
|a 08878013 (ISSN)
|
245 |
1 |
0 |
|a The clinical significance of vitamin D levels and vitamin D receptor mRNA expression in colorectal neoplasms
|
260 |
|
0 |
|b John Wiley and Sons Inc
|c 2021
|
856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.1002/jcla.23988
|
520 |
3 |
|
|a Background/Aim: This study aimed to investigate the clinical significance of changes in vitamin D [25(OH)D] levels and vitamin D receptor (VDR) mRNA expression in colorectal adenoma development. Methods: Plasma concentrations of 25(OH)D and mRNA expression of VDR in tissues were determined by enzyme-linked immunosorbent assay (ELISA) and real-time fluorescence quantitative polymerase chain reaction (RT-qPCR), respectively. In addition, the concentration of plasma 25(OH)D and levels of VDR mRNA in tissues were compared among healthy individuals and adenoma and adenocarcinoma patients. Results: Vitamin D receptor expression in colorectal adenocarcinoma tissues was significantly lower than that in para-cancerous tissues that were >5 cm away from malignant tumor sites (p < 0.01). The level of VDR expression in normal colorectal tissues from healthy individuals was significantly higher than that in colorectal adenomas (p < 0.01) and colorectal adenocarcinomas (p < 0.01); however, the VDR expression was not significantly different between colorectal adenomas and colorectal adenocarcinomas (p = 0.106). The concentration of 25(OH)D in healthy individuals was significantly higher than that in patients with colorectal adenomas (p < 0.01) and colorectal adenocarcinomas (p < 0.01); however, the concentration of 25(OH)D was not significantly different between colorectal adenomas and colorectal adenocarcinomas (p = 0.489). A low concentration of 25(OH)D was considered a risk factor for colorectal adenoma and colorectal adenocarcinoma, with odds ratios of 4.875 and 2.925, respectively. Conclusions: The 25(OH)D levels and VDR mRNA expression might be associated with the development of colorectal adenoma and its progression to adenocarcinoma. © 2021 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC.
|
650 |
0 |
4 |
|a 25 hydroxyvitamin D
|
650 |
0 |
4 |
|a adenocarcinoma
|
650 |
0 |
4 |
|a Adenocarcinoma
|
650 |
0 |
4 |
|a adenoma
|
650 |
0 |
4 |
|a Adenoma
|
650 |
0 |
4 |
|a adult
|
650 |
0 |
4 |
|a Article
|
650 |
0 |
4 |
|a blood
|
650 |
0 |
4 |
|a calcitriol receptor
|
650 |
0 |
4 |
|a cancer growth
|
650 |
0 |
4 |
|a cancer risk
|
650 |
0 |
4 |
|a cancer tissue
|
650 |
0 |
4 |
|a carcinogenesis
|
650 |
0 |
4 |
|a case control study
|
650 |
0 |
4 |
|a colon
|
650 |
0 |
4 |
|a Colon
|
650 |
0 |
4 |
|a colorectal adenocarcinoma
|
650 |
0 |
4 |
|a colorectal adenoma
|
650 |
0 |
4 |
|a colorectal adenoma
|
650 |
0 |
4 |
|a colorectal carcinoma
|
650 |
0 |
4 |
|a Colorectal Neoplasms
|
650 |
0 |
4 |
|a colorectal tumor
|
650 |
0 |
4 |
|a controlled study
|
650 |
0 |
4 |
|a enzyme linked immunosorbent assay
|
650 |
0 |
4 |
|a female
|
650 |
0 |
4 |
|a Female
|
650 |
0 |
4 |
|a fluorescence quantitative polymerase chain reaction
|
650 |
0 |
4 |
|a genetics
|
650 |
0 |
4 |
|a human
|
650 |
0 |
4 |
|a human tissue
|
650 |
0 |
4 |
|a Humans
|
650 |
0 |
4 |
|a major clinical study
|
650 |
0 |
4 |
|a male
|
650 |
0 |
4 |
|a Male
|
650 |
0 |
4 |
|a messenger RNA
|
650 |
0 |
4 |
|a messenger RNA
|
650 |
0 |
4 |
|a metabolism
|
650 |
0 |
4 |
|a middle aged
|
650 |
0 |
4 |
|a Middle Aged
|
650 |
0 |
4 |
|a mRNA expression level
|
650 |
0 |
4 |
|a Receptors, Calcitriol
|
650 |
0 |
4 |
|a RNA, Messenger
|
650 |
0 |
4 |
|a VDR protein, human
|
650 |
0 |
4 |
|a vitamin blood level
|
650 |
0 |
4 |
|a vitamin D
|
650 |
0 |
4 |
|a vitamin D
|
650 |
0 |
4 |
|a Vitamin D
|
650 |
0 |
4 |
|a vitamin D receptor
|
650 |
0 |
4 |
|a vitamin D receptor
|
700 |
1 |
|
|a Ding, X.
|e author
|
700 |
1 |
|
|a Fang, Y.
|e author
|
700 |
1 |
|
|a Huang, J.
|e author
|
700 |
1 |
|
|a Song, H.
|e author
|
700 |
1 |
|
|a Zhou, J.
|e author
|
773 |
|
|
|t Journal of Clinical Laboratory Analysis
|